# Oobli

describes itself as the first and only commercial-scale sweet-protein technology platform; received its third FDA "no questions" letter in September 2025 for its brazzein-based sweetening ingredient, and announced an Andean regional manufacturing partnership in April 2026 with Magdalena,…

Source: https://en.bioecon.ru/companies/oobli/
Updated: 2026-08-15

- Country: United States

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Funding | Approximately $43M - $50M in total funding raised to date | https://oobli.com/blogs/news/oobli-and-ingredion-announce-partnership-as-demand-for-sweet-proteins-accelerates, https://www.caplight.com/company/oobli |
| Production site | Research lab in Davis, California; manufacturing conducted at a contract facility in Los Angeles, California | https://www.wyomingnews.com/features/calif-startup-releases-unique-sweet-tea-here-s-what-makes-it-different/article_fef353bc-3ba9-11ee-9eaf-93dba7b429a7.html |
| Certification | Three FDA GRAS 'no questions' letters; multiple proteins with self-affirmed FDA GRAS status; one protein with FEMA GRAS status | https://oobli.com/blogs/news/oobli-and-ingredion-announce-partnership-as-demand-for-sweet-proteins-accelerates, https://oobli.com/pages/regulatory, https://oobli.com/pages/sweet-protein-ingredients-for-food-and-beverage-brands |
| Regulatory approval | Three FDA 'no questions' letters received (as of September 2025) | https://oobli.com/blogs/news/oobli-receives-third-no-questions-letter-from-the-fda-for-use-of-novel-sweet-protein-as-a-sweetening-ingredient, https://oobli.com/pages/sweet-protein-ingredients-for-food-and-beverage-brands, https://www.prnewswire.com/news-releases/oobli-receives-third-no-questions-letter-from-the-fda-for-use-of-novel-sweet-protein-as-a-sweetening-ingredient-302566197.html, https://www.proteinproductiontechnology.com/post/oobli-earns-third-fda-no-questions-letter-for-its-sweet-protein-platform-expanding-sugar-free-innovation |
| Headcount | Approximately 42-45 employees [medium confidence] | https://bouncewatch.com/company/oobli, https://prospeo.io/c/oobli, https://www.datanyze.com/companies/oobli/566133951 |
| Revenue | Estimated between $3.8M and $39.7M annually [medium confidence] | https://prospeo.io/c/oobli, https://www.datanyze.com/companies/oobli/566133951 |

Independent sources: bouncewatch.com, caplight.com, datanyze.com, prnewswire.com, prospeo.io, proteinproductiontechnology.com, wyomingnews.com

## Technologies

- [Sweet proteins (brazzein, thaumatin, monellin)](https://en.bioecon.ru/technology/sweet-proteins-brazzein-thaumatin-monellin/)